KIERA HALLIGAN: Open Payments
NPI 1689142168 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 63 payments from 13 companies in 2025. Trend: 2023 $98 · 2024 $93 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $287 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $228 |
| Lilly USA, LLC | 11 | $219 |
| Novo Nordisk Inc | 11 | $175 |
| AstraZeneca Pharmaceuticals LP | 5 | $142 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $37 |
| Astellas Pharma US Inc | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
Products named: VRAYLAR, Kerendia, MOUNJARO, Ozempic, AIRSUPRA, JARDIANCE, BREZTRI, Belbuca.
Industry payments across NY — which companies pay providers there.
